Benzodiazepines: A Reevaluation of Their Benefits and Dangers
The Carlat Psychiatry Report, Volume 20, Number 6, June 2022
https://www.thecarlatreport.com/newsletter-issue/tcprv20n67/
Issue Links: Learning Objectives | Editorial Information
Topics: Anxiety | Anxiety Disorder | Benzodiazepines | Hypnotics
Carl Salzman, MD
Professor of Psychiatry at Harvard Medical School and past chairman of the American Psychiatric Association Benzodiazepine Task Force.
Interview by Marcia L. Zuckerman, MD. Board member of The Carlat Psychiatry Report; outpatient psychiatrist, Hallmark Health, Medford, MA; clinical assistant professor in psychiatry, Tufts School of Medicine. Edited by Chris Aiken, MD. Editor-in-Chief of TCPR; practicing psychiatrist, Winston-Salem, NC.
Drs. Salzman, Zuckerman, and Aiken have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Former Chairman of the American Psychiatric Association Benzodiazepine Task Force Carl Salzman explains the legitimate medical use of benzodiazepines and their relevance in psychiatric practice.
You can't view details of this content, please login or buy subscription here